Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial
Top Cited Papers
- 6 May 2011
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 26 (9), 1755-1759
- https://doi.org/10.1002/mds.23751
Abstract
Background: The safety and efficacy of the oral iron‐chelating agent deferiprone on magnetic resonance pallida iron concentration and on clinical status were investigated in 10 patients affected by pantothenate kinase–associated neurodegeneration. Methods: Nine patients (age range, 7–39 years) completed the study. Results: A significant median reduction in globus pallidus iron content as assessed by T2* relaxometry (and calculated R2* maps; P = .008) was observed at the end of the study. None of the patients demonstrated a change in clinical status as assessed by the Burke‐Fahn and Marsden Dystonia Rating scales and by a health‐related quality‐of‐life scale. Deferiprone was well tolerated, and no serious adverse events occurred. Conclusions: Future trials assessing the clinical efficacy of chelating therapy should consider early symptomatic patients and a longer treatment period. © 2011 MovementDisorder SocietyKeywords
This publication has 22 references indexed in Scilit:
- Age-related Iron Deposition in the Basal Ganglia: Quantitative Analysis in Healthy SubjectsRadiology, 2009
- Iron accumulation in syndromes of neurodegeneration with brain iron accumulation 1 and 2: causative or consequential?Journal of Neurology, Neurosurgery & Psychiatry, 2009
- Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulationMovement Disorders, 2008
- Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic ImplicationsNeurotherapeutics, 2007
- Safety and effectiveness of long-term therapy with the oral iron chelator deferiproneBlood, 2003
- Rating scales for dystonia: A multicenter assessmentMovement Disorders, 2002
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in lifeZeitschrift für Neurologie, 1992
- Hallervorden‐spatz syndrome: Clinical and magnetic resonance imaging correlationsAnnals of Neurology, 1988
- Hallervorden‐Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidusAnnals of Neurology, 1985